Randomized Phase 2 Trial for Patients with Dry Age-Related Macular Degeneration (AMD)

University Hospitals is a participating site in a worldwide study aimed to slow the progression of Geographic Atrophy (GA), an eye disease resulting from Age-Related Macular Degeneration (AMD). GA is a condition in which there is loss or thinning of the tissue found in the central portion of the back of the eye (retina). This loss or thinning of this tissue can lead to vision loss that often begins in the central field of view. The research project is testing an experimental drug for GA secondary to AMD called ISIS 696844.

Patients 50 years and older maybe eligible for this study.